MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today announced that the first patient has been dosed in ...

Rocket Pharmaceuticals advances gene therapies for rare diseases. Momentum aligns with broader biotech trends in the Nasdaq ...

A study from St. Jude Children's Research Hospital uncovered an alternative binding pocket within nuclear receptors, ...

Now, a growing body of scientific evidence shows hundreds of genes act differently in the brains of biologically male or ...

By Vijay Kumar Malesu Scientists have uncovered a microglial switch that transforms these immune cells from plaque-promoting ...

A week-long retreat combining meditation and mind-body healing produced significant changes in brain activity and blood ...

Alzheimer’s disease is a progressive brain disorder that results in loss of cognitive function. Patients with Alzheimer’s ...

November 6, 2025) A study from St. Jude Children's Research Hospital uncovered an alternative binding pocket within nuclear ...

Vizgen, Inc., a spatial multi-omics innovator accelerating biological discovery and new drug development, today announced that it will present new spatial multi-omics data at the Society for ...

In the UK, there was a case where TGN1412, an immunotherapy under development, triggered a cytokine storm within hours of administration to humans ...

The two main approaches for discovering disease genes reveal distinct aspects of biology, a new study shows. While both ...

MIT researchers developed a tool called KATMAP that shows how cells use the same genes in different ways to make unique ...